PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsSezary syndrome
MeSH D012751 - sezary syndrome
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D008232:Lymphoproliferative disorders
$
Success rate
D016410:T-cell lymphoma cutaneous
$
Success rate
D012751: 
Sezary syndrome
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Horizon Therapeutics PublicInterferon gamma-1b Actimmune  1999-02-25 $122.816 M Q3/22-Q2/23 
Kyowa KirinMogamulizumab Poteligeo  2018-08-08   
Clinical Trials
Historical Success Rate
Phase 1
56%
18/32
Phase 2
0%
0/25
Phase 3
80%
8/10
Approved: 8Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Kyowa Kirin
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use